Trial NCT03003728

View at ClinicalTrials.gov 
Org. Study IDs: 205009

Last trial update was posted on 2020-07-10

MeSH Interventions

Elotuzumab Melphalan

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

Withdrawal of study support

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID